Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glucotrack (GCTK) Return on Equity (2016 - 2020)

Glucotrack's Return on Equity history spans 6 years, with the latest figure at 0.41% for Q3 2020.

  • For the quarter ending Q3 2020, Return on Equity fell 398.0% year-over-year to 0.41%, compared with a TTM value of 0.41% through Sep 2020, down 398.0%, and an annual FY2019 reading of 1.64%, down 231.0% over the prior year.
  • Return on Equity for Q3 2020 was 0.41% at Glucotrack, up from 0.38% in the prior quarter.
  • The five-year high for Return on Equity was 4.39% in Q3 2019, with the low at 4.88% in Q4 2019.
  • Average Return on Equity over 5 years is 0.12%, with a median of 0.29% recorded in 2018.
  • Biggest YoY gain for Return on Equity was 541bps in 2019; the steepest drop was -517bps in 2019.
  • Tracing GCTK's Return on Equity over 5 years: stood at 0.54% in 2016, then tumbled by -285bps to 1.0% in 2017, then surged by 129bps to 0.29% in 2018, then plummeted by -1795bps to 4.88% in 2019, then skyrocketed by 108bps to 0.41% in 2020.
  • Per Business Quant, the three most recent readings for GCTK's Return on Equity are 0.41% (Q3 2020), 0.38% (Q2 2020), and 0.79% (Q1 2020).